){kind=logo}
Loeb & Loeb represented the underwriter, Roth Capital Partners, in connection with the initial public offering of Synergy CHC Corporation, a provider of consumer health care, beauty and lifestyle products.
The company began trading on the Nasdaq Global Market on October 23, 2024, under the ticker “SYNR,” with 1.15 million shares of common stock priced at $9.00 each. In addition, Synergy granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of common stock at the public offering price less underwriting discounts and commissions.
The offering raised approximately $8.4 million in net proceeds after deducting underwriting costs. Roth Capital Partners acted as the sole underwriter for the offering.
The Loeb team included Loeb & Loeb Co-Chair Mitch Nussbaum, Capital Markets & Corporate partners Alexandria Kane and Lili Taheri, and associate George Du.
For more information, please see Synergy CHC’s press release.
The company began trading on the Nasdaq Global Market on October 23, 2024, under the ticker “SYNR,” with 1.15 million shares of common stock priced at $9.00 each. In addition, Synergy granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of common stock at the public offering price less underwriting discounts and commissions.
The offering raised approximately $8.4 million in net proceeds after deducting underwriting costs. Roth Capital Partners acted as the sole underwriter for the offering.
The Loeb team included Loeb & Loeb Co-Chair Mitch Nussbaum, Capital Markets & Corporate partners Alexandria Kane and Lili Taheri, and associate George Du.
For more information, please see Synergy CHC’s press release.
-
Co-Chair, Loeb & Loeb LLP -
Partner -
Partner
-
Associate